Emmecell Completes Final Cell Therapy Dosing in U.S. Clinical Trial for Corneal Edema
Accesswire
*MENLO PARK, CA / ACCESSWIRE / April 30, 2024 / *Emmetrope Ophthalmics LLC ("Emmecell"), a clinical-stage biotechnology company..
*MENLO PARK, CA / ACCESSWIRE / April 30, 2024 / *Emmetrope Ophthalmics LLC ("Emmecell"), a clinical-stage biotechnology company..
LOS ANGELES--(BUSINESS WIRE)-- #TogetherWeWin--Banc of California, Inc. (NYSE: BANC) today announced that Michael David has joined..
Meta Platforms Inc. tripled its profit and posted sharply higher revenue in the final quarter of 2023, boosted by a rebound in..